Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flunarizine for Treatment Resistant Absence Epilepsy
NCT06153186Phase 2Terminated
- Sponsor
- University of British Columbia
- Start
- Sep 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flunarizine in childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), sponsored by University of British Columbia. Started Sep 2019; status: terminated.
02
Drugs
flunarizine
03
Conditions
childhood absence epilepsy (CAE)juvenile absence epilepsy (JAE)juvenile myoclonic epilepsy (JME)
Beyond the preview
Go deeper on NCT06153186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153186.